@LegDvt

Vascular surgeon with special interest in pathogenesis of thrombosis, its prevention and treatment in all ages, in the hospitals, communities.

 Hyderabad, India
apvascular.blogspot.in
Joined August 2012
  • Tweets90
  • Following320
  • Followers193
8Media
We don't recommend aspirin for primary prophylaxis: magzter.com/share/clip/16342…
Can you believe this? Recurrent VTE is 72% within 21 days after initial event while on DVT treatment.thrombosisjournal.com/conten…
1
3
1
6
Benefits and harms of #e-cigarettes remain unanswered.find - World no nicotine day thelancet.com/journals/lance…
1
#Rivaroxaban resulted in greater benefits than harms compared with #enoxaparin RECORD studies ncbi.nlm.nih.gov/pubmed/2470…

Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembo...

In the RECORD studies, considering death, symptomatic venous thromboembolism, and major bleeding, rivaroxaban resulted in greater benefits than harms compared with enoxaparin. When incorporating...

pubmed.ncbi.nlm.nih.gov
1
Carriers of #FVL #mutation had a significantly lower urine albumin excretion, tended to have lower plasma creatinine ncbi.nlm.nih.gov/pubmed/2472…

Lower plasma creatinine and urine albumin in individuals at increased risk of type 2 diabetes with...

The factor V Leiden (FVL) mutation is the most frequent genetic cause of venous thrombosis in Caucasians. However, protective effects have been suggested to balance the disadvantages. We have...

pubmed.ncbi.nlm.nih.gov
1
“Venous thrombosis: who should be screened for thrombophilia in 2014?pamw.pl/sites/default/files/…
1
COPD is the third leading cause of death in USA. New technology is helping these breathe easier live longer. fw.to/wiD7rQR
1
Genotype-guided dosing of warfarin did not improve anticoagulation control during the first 4 weeks of therapy.
30% of those diagnosed with sepsis die.Sepsis kills more people than breast cancer, prostate cancer, AIDS combined.sciencedaily.com/releases/20…

Biomedical scientist discovers method to increase survival in sepsis

Sepsis, the body's response to severe infections, kills more people than breast cancer, prostate cancer and HIV/AIDS combined. On average, 30 percent of those diagnosed with sepsis die.

sciencedaily.com
1
A strong dose-response relation for higher red cell distribution width and monocytes with risk of DVT found. ncbi.nlm.nih.gov/pubmed/2389…
Mutation in Prothrombin (G20210A]) is one of the factors involved in traumatic pts with DVT despite prophylaxis.ncbi.nlm.nih.gov/pubmed/2389…
Successful treatment of acute portal vein thrombosis with rivaroxaban 20 mg per day lead to complete recanalization. ncbi.nlm.nih.gov/pubmed/2384…

Successful treatment of acute portal vein thrombosis with rivaroxaban - PubMed

Successful treatment of acute portal vein thrombosis with rivaroxaban

pubmed.ncbi.nlm.nih.gov
The CaseFatalityRate of rec. VTE was higher in patients initially presenting with PE and in those with provoked VTE. ncbi.nlm.nih.gov/pubmed/2384…
Large and significant reduction in death rates from #CHD over the past three decades in both women and men across Europe published in #EHJ
All patients with prior #SVT were found to be six times more likely to develop #DVT and four times more likely to develop #PE than controls.
Newly spotted human eye layer named after Indian scientist shar.es/x1fwz via @sharethis
1
Predictive model for #chemotherapy associated #thrombosis include site of #cancer,platelets, HB%,WBC,BMI >35. ncbi.nlm.nih.gov/pubmed/1821…
In #cancer, compared to local stage -regional stage and distant stage had higher #VTE risk. ncbi.nlm.nih.gov/pubmed/2358…

Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from...

Advanced cancer is a risk factor for venous thromboembolism. However, lymph node metastases are usually not considered an established risk factor. In the framework of the prospective, observational...

pubmed.ncbi.nlm.nih.gov
#Anticoagulant therapy safe and effective for treatment of #pregnancy-related VTE, optimal dosing regimens uncertain.onlinelibrary.wiley.com/doi/…
1
Load more